je.st
news
Tag: merck
Bruce Kuhlik and Merck Honored by PBI for Commitment to Pro Bono
2013-02-28 15:43:01| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. and WASHINGTON, D.C. Merck, known as MSD outside the United States and Canada, today announced that the Pro Bono Institute (PBI) has selected Executive Vice President and General Counsel Bruce Kuhlik and the companys legal department as the winner of the 2013 Laurie D. Zelon Pro Bono Award for their outstanding commitment to pro bono service. Language: English Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: to
pro
commitment
bruce
Merck Announces Second-Quarter 2013 Dividend
2013-02-26 20:29:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.43 per share on the companys common stock for the second quarter of 2013. Payment will be made on Apr. 5, 2013, to stockholders of record at the close of business on Mar. 15, 2013. About Merck Language: English Contact HTML: MerckMedia:Ron Rogers, 908-423-6449orInvestors:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: announces
dividend
merck
announces dividend
Merck to Present at the Citi 2013 Global Healthcare Conference
2013-02-26 14:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the Citi 2013 Global Healthcare Conference in New York on February 27 at 9:35 a.m. EST. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at http://www.merck.com/investors/events-and-presentations/home.html. About Merck Language: English Contact HTML: MerckMedia:Ron Rogers, 908-423-6449orInvestors:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: present
global
conference
healthcare
Merck KGaA brain tumor drug fails clinical trial
2013-02-25 15:33:17| Biotech - Topix.net
Merck KGaA's Cilengitide, an experimental drug to treat an aggressive type of brain tumor, has failed a large-scale clinical trial, dealing a blow to the German drugmaker's efforts to replenish its pipeline of medicines.
Tags: trial
drug
clinical
brain
Pa. AG announces settlement with Merck over Vioxx
2013-02-23 05:03:03| Biotech - Topix.net
Weather Alert: Winter Weather Advisory expires at 4:00 PM on 2/22, issued at 3:29 PM Jamestown, PA Weather Alert: Winter Weather Advisory expires at 6:00 PM on 2/22, issued at 3:05 PM Columbiana, OH Weather Alert: Winter Weather Advisory expires at 10:00 PM on 2/22, issued at 3:05 PM Bessemer, PA Pennsylvania's attorney general is announcing an ... (more)
Tags: settlement
announces
merck
vioxx
Sites : [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] next »